Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Personalized Medicine in Functional Gastrointestinal Disorders: Understanding Pathogenesis to Increase Diagnostic and Treatment Efficacy
World Journal of Gastroenterology, 25(10):1185-1196
Lectura recomendada:
Strong Association Between Metabolically-abnormal Obesity and Gallstone Disease in Adults Under 50 years
BMC Gastroenterology, 19:1-6
Lectura recomendada:
Rifaximin Is Associated With Modest, Transient Decreases in Multiple Taxa in the Gut Microbiota of Patients With Diarrhoea-Predominant Irritable Bowel Syndrome
Gut Microbes, 10(1):22-33
Lectura recomendada:
Aspirin and the Risk of Colorectal and Other Digestive Tract Cancers: an Updated Meta-analysis Through 2019
Annals of Oncology, 31(5):558-568
Lectura recomendada:
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial
Gastroenterology, 158(1):1760-188
Lectura recomendada:
AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders
Gastroenterology, :1-28
Lectura recomendada:
Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome in a Randomised, Double-blind, Placebo-controlled Study
Gut, 69(5):859-867
Lectura recomendada:
Long-term Changes of gut Microbiota, Antibiotic Resistance, and Metabolic Parameters after Helicobacter Pylori Eradication: a Multicentre, Open-label, Randomised Trial
The Lancet Infectious Diseases, 19(10):1109-1120
Lectura recomendada:
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole
Pharmacology, :1-7
Lectura recomendada:
Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection
Internal Medicine, 58(2):159-166
Lectura recomendada:
Eficacia del Tratamiento con Omeprazol y Bicarbonato de Sodio en la Enfermedad por Reflujo Gastroesofágico: Revisión Sistemática
Medwave, 18(2):1-6
El esomeprazol administrado después de las comidas:
Introducción:
Los inhibidores de la bomba de protones son eficaces para el tratamiento de los síntomas de reflujo secundarios a la enfermedad por reflujo gastroesofágico. Aún se estudia si la administración posprandial es igual de eficaz que la indicación preprandial.
Lectura recomendada:
Effect of Postprandial Administration of Esomeprazole on Reflux Symptoms in Gastroesophageal Reflux Disease: A Randomized, Controlled Trial
Digestive Diseases, 36(4):257-263
Lectura recomendada:
On-demand versus Half-Dose Continuous Therapy with Esomeprazole for Maintenance Treatment of Gastroesophageal Reflux Disease: A Randomized Comparative Study
Medicine (Baltimore), 97(43):1-8
Lectura recomendada:
Sustained Efficacy Following Resolution of Frequent Heartburn with an Over-the-counter Regimen of Esomeprazole 20 mg or Placebo for 14 Days: Two Randomized Trials
BMC Gastroenterology, 18(69):1-8
Lectura recomendada:
A Randomized, Crossover Pharmacodynamic Study of Immediate-release Omeprazole/Sodium Bicarbonate and
Delayed-release Lansoprazole in Healthy Adult Volunteers
Pharmacology Research & Perspectives, 4(3):1-9
Lectura recomendada:
Analysis of the Symptom Response to Esomeprazole 20 mg over days 1–4 of a 14-day Course of Treatment for Frequent Heartburn: Results of two Randomised Controlled Trials
BMJ Open Gastroenterology, 6(1):1-7
Lectura recomendada:
Long-term Treatment with Proton Pump Inhibitors is Effective in Children with Eosinophilic Esophagitis
Journal of Pediatric Gastroenterology and Nutrition, 67(2):210-216
Lectura recomendada:
The Effect of Early Helicobacter Pylori Eradication on the Healing of ESD-induced Artificial Ulcers A Retrospective Study
Medicine (Baltimore), 98(22):1-5
Lectura recomendada:
Helicobacter Pylori Eradication Regimens in an Antibiotic High-resistance European area: A Cost-effectiveness Analysis
Helicobacter, 25(1):1-9